Vanguard Group
CDMO

Vanguard Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Vanguard Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,771,069
Closed -$46.6M – 4334
2024
Q4 		$46.6M Sell
3,771,069
-75,314
-2% -$863K ﹤0.01% 2193
2024
Q3 		$43.8M Buy
3,846,383
+48,237
+1% +$484K ﹤0.01% 2233
2024
Q2 		$27.1M Buy
3,798,146
+132,958
+4% +$1.02M ﹤0.01% 2422
2024
Q1 		$24.6M Buy
3,665,188
+47,315
+1% +$326K ﹤0.01% 2495
2023
Q4 		$23.5M Sell
3,617,873
-809,149
-18% -$5.21M ﹤0.01% 2517
2023
Q3 		$41.8M Buy
4,427,022
+13,190
+0.3% +$159K ﹤0.01% 2211
2023
Q2 		$61.7M Buy
4,413,832
+19,830
+0.5% +$338K ﹤0.01% 2094
2023
Q1 		$82.4M Buy
4,394,002
+44,712
+1% +$734K ﹤0.01% 1913
2022
Q4 		$59.9M Buy
4,349,290
+130,365
+3% +$2M ﹤0.01% 2090
2022
Q3 		$80.7M Buy
4,218,925
+275,783
+7% +$5.02M ﹤0.01% 1926
2022
Q2 		$60.2M Sell
3,943,142
-170,115
-4% -$2.52M ﹤0.01% 2104
2022
Q1 		$83.8M Buy
4,113,257
+102,541
+3% +$2.09M ﹤0.01% 2047
2021
Q4 		$117M Buy
4,010,716
+830,378
+26% +$23.8M ﹤0.01% 1904
2021
Q3 		$68.6M Buy
3,180,338
+44,955
+1% +$1.09M ﹤0.01% 2190
2021
Q2 		$80.4M Buy
3,135,383
+274,746
+10% +$5.87M ﹤0.01% 2112
2021
Q1 		$52.1M Buy
2,860,637
+108,460
+4% +$1.8M ﹤0.01% 2291
2020
Q4 		$31.8M Buy
2,752,177
+92,439
+3% +$845K ﹤0.01% 2418
2020
Q3 		$20.3M Sell
2,659,738
-19,553
-0.7% -$148K ﹤0.01% 2452
2020
Q2 		$17.6M Buy
2,679,291
+41,246
+2% +$230K ﹤0.01% 2482
2020
Q1 		$13.5M Buy
2,638,045
+57,499
+2% +$348K ﹤0.01% 2478
2019
Q4 		$19.8M Sell
2,580,546
-98,873
-4% -$577K ﹤0.01% 2538
2019
Q3 		$14.2M Buy
2,679,419
+3,417
+0.1% +$21.2K ﹤0.01% 2639
2019
Q2 		$15M Buy
2,676,002
+19,667
+0.7% +$81.1K ﹤0.01% 2656
2019
Q1 		$11.3M Buy
2,656,335
+224,939
+9% +$918K ﹤0.01% 2759
2018
Q4 		$9.97M Buy
2,431,396
+101,198
+4% +$528K ﹤0.01% 2777
2018
Q3 		$16M Buy
2,330,198
+120,673
+5% +$715K ﹤0.01% 2691
2018
Q2 		$8.66M Buy
2,209,525
+250,155
+13% +$868K ﹤0.01% 2972
2018
Q1 		$5.72M Buy
1,959,370
+516,714
+36% +$1.6M ﹤0.01% 3082
2017
Q4 		$5.6M Sell
1,442,656
-75,454
-5% -$323K ﹤0.01% 3085
2017
Q3 		$4.77M Buy
1,518,110
+488,376
+47% +$1.83M ﹤0.01% 3142
2017
Q2 		$4.38M Buy
1,029,734
+146,788
+17% +$601K ﹤0.01% 3133
2017
Q1 		$4.04M Buy
882,946
+267,432
+43% +$896K ﹤0.01% 3143
2016
Q4 		$1.33M Sell
615,514
-557,966
-48% -$1.3M ﹤0.01% 3489
2016
Q3 		$3.53M Sell
1,173,480
-12,881
-1% -$34.6K ﹤0.01% 3162
2016
Q2 		$3.02M Sell
1,186,361
-63,375
-5% -$177K ﹤0.01% 3214
2016
Q1 		$3.68M Buy
1,249,736
+351,913
+39% +$1.88M ﹤0.01% 3119
2015
Q4 		$7.35M Buy
897,823
+38,273
+4% +$309K ﹤0.01% 2803
2015
Q3 		$6.14M Buy
859,550
+68,415
+9% +$571K ﹤0.01% 2874
2015
Q2 		$7.25M Buy
791,135
+26,104
+3% +$251K ﹤0.01% 2836
2015
Q1 		$7.23M Buy
765,031
+33,406
+5% +$322K ﹤0.01% 2806
2014
Q4 		$7.12M Buy
731,625
+8,251
+1% +$83.1K ﹤0.01% 2711
2014
Q3 		$6.89M Buy
723,374
+29,393
+4% +$329K ﹤0.01% 2671
2014
Q2 		$9.13M Buy
693,981
+13,394
+2% +$169K ﹤0.01% 2546
2014
Q1 		$9.05M Buy
680,587
+81,654
+14% +$1.08M ﹤0.01% 2539
2013
Q4 		$5.83M Buy
598,933
+49,295
+9% +$464K ﹤0.01% 2715
2013
Q3 		$5.42M Buy
549,638
+60,592
+12% +$602K ﹤0.01% 2697
2013
Q2 		$4.42M Buy
+489,046
New +$5.13M ﹤0.01% 2737

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's CDMO Position: Q1 2025 in Review

Vanguard Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 3,771,069 shares — an estimated $46.6M sold.

Vanguard Group first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $117M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Vanguard Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Vanguard Group sold 3,771,069 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $46.6M.
  • Vanguard Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • Vanguard Group's Avid Bioservices, Inc. Common Stock position peaked at $117M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.